Please Note: This trial is no longer enrolling new participants
Genotype-directed Phase II Study of Irinotecan Dosing in Metastatic Colorectal Cancer (mCRC) Patients Receiving FOLFIRI + Bevacizumab
Protocol No. | LCCC1317 | Scope | National |
---|---|---|---|
Principal Investigator | Patrick Loehrer | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase II |